1. Home
  2. GIS vs UTHR Comparison

GIS vs UTHR Comparison

Compare GIS & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GIS

General Mills Inc.

HOLD

Current Price

$44.24

Market Cap

24.9B

ML Signal

HOLD

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$466.28

Market Cap

21.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GIS
UTHR
Founded
1866
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.9B
21.4B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
GIS
UTHR
Price
$44.24
$466.28
Analyst Decision
Hold
Buy
Analyst Count
15
12
Target Price
$53.27
$498.83
AVG Volume (30 Days)
8.2M
346.5K
Earning Date
03-18-2026
02-25-2026
Dividend Yield
5.46%
N/A
EPS Growth
0.65
16.08
EPS
4.63
26.38
Revenue
$18,776,700,000.00
$3,128,400,000.00
Revenue This Year
N/A
$13.64
Revenue Next Year
N/A
$5.66
P/E Ratio
$9.66
$18.08
Revenue Growth
N/A
13.50
52 Week Low
$42.79
$266.98
52 Week High
$67.35
$519.99

Technical Indicators

Market Signals
Indicator
GIS
UTHR
Relative Strength Index (RSI) 42.81 39.73
Support Level $44.29 $464.16
Resistance Level $44.88 $479.41
Average True Range (ATR) 0.98 10.35
MACD 0.07 -1.47
Stochastic Oscillator 48.25 21.75

Price Performance

Historical Comparison
GIS
UTHR

About GIS General Mills Inc.

General Mills is a global packaged-food company that produces snacks, cereal, convenient meals, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Pillsbury, Betty Crocker, Blue Buffalo, and Haagen-Dazs. In fiscal 2025, 81% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. Although most of General Mills' products are sold through retail stores to consumers, the company also sells products to the foodservice channel and the commercial baking industry.

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.

Share on Social Networks: